ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

CTEP Deploys Website To Track Trial Activation

December 10, 2010

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999